Masafumi Shionyu Selected Research

tecadenoson

1/2020

Knowledge-based structural models of SARS-CoV-2 proteins and their complexes with potential drugs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masafumi Shionyu Research Topics

Disease

3	Neoplasms (Cancer) 11/2019 - 02/2018
2	COVID-19 01/2021 - 01/2020
1	Carcinogenesis 11/2019
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2019
1	Adenocarcinoma 10/2019
1	Leukemia 10/2019
1	Rare Diseases (Rare Disease) 01/2008

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2008
2	Pharmaceutical PreparationsIBA 01/2021 - 11/2019
2	CurcuminIBA 11/2019 - 10/2019
2	EnzymesIBA 11/2019 - 10/2019
1	Antiviral Agents (Antivirals)IBA 01/2021
1	trabodenosonIBA 01/2020
1	carfilzomibIBA 01/2020
1	tecadenosonIBA 01/2020
1	sinefunginIBA 01/2020
1	AntioxidantsIBA 11/2019
1	Cysteine (L-Cysteine)FDA Link 11/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2019
1	Cell-Penetrating PeptidesIBA 02/2018
1	Proteasome InhibitorsIBA 02/2018

Therapy/Procedure

1	Oral Administration 10/2019